Muscle & Aging
What Happens to Muscle During Bed Rest or Immobilisation?
The short answer
It starts fast and keeps compounding. In one trial, young men lost 3.5% of quadriceps cross-sectional area and 9.0% of knee-extensor strength after just 5 days of one-legged immobilization; by 14 days in the same trial design, the losses had grown to 8.4% of muscle area and 22.9% of strength. A separate 10-day trial in young women found a much steeper 41.6% strength loss over a similar timeframe, underscoring how much the exact numbers can vary between studies, sexes, and testing methods. A small amount of resistance exercise during immobilization blunted the losses in one trial. But even a sophisticated 60-day bed-rest countermeasure combining exercise and artificial gravity did not fully protect contractile muscle function, despite preserving other tissue and metabolic measures.
Quick answers
- What is it?
- This covers what happens to muscle size and strength when a limb is immobilized or a person is confined to bed rest, and how quickly that loss begins.
- Why are people interested in it?
- Anyone facing surgery, a cast, an illness, or hospitalization wants to know how much muscle they stand to lose and how fast.
- What has actually been studied?
- Randomized and controlled trials of one- and two-legged immobilization (5-14 days) and bed rest (up to 60 days) in young, mostly healthy adults, including trials testing low-volume resistance exercise and artificial gravity as countermeasures.
- How strong is the evidence?
- Solid within young healthy adults: multiple controlled trials consistently show measurable muscle and strength loss within just 5 days, though the exact rate varies considerably between studies by sex, sample, and testing method.
- What don't we know yet?
- Why the loss rate varies so much between studies, how long recovery takes once normal activity resumes, whether any countermeasure fully protects neuromuscular function over longer durations, and whether the same rates apply outside young, healthy volunteers.
- Where can I read the original research?
- Sources at the bottom of this page: Wall BT, Dirks ML, Snijders T, et al., Acta Physiologica, 2013; and Thom JM, Thompson MW, Ruell PA, et al., Acta Physiologica Scandinavica, 2001.
The short answer: It starts fast and keeps compounding. In one trial, young men lost 3.5% of quadriceps cross-sectional area and 9.0% of knee-extensor strength after just 5 days of one-legged immobilization; by 14 days in the same trial design, the losses had grown to 8.4% of muscle area and 22.9% of strength. A separate 10-day trial in young women found a much steeper 41.6% strength loss over a similar timeframe, underscoring how much the exact numbers can vary between studies, sexes, and testing methods. A small amount of resistance exercise during immobilization blunted the losses in one trial. But even a sophisticated 60-day bed-rest countermeasure combining exercise and artificial gravity did not fully protect contractile muscle function, despite preserving other tissue and metabolic measures.
What the research shows
It starts within days, not weeks
A trial designed specifically to test how fast disuse atrophy begins put 24 healthy young men (23 ± 1 years) through either 5 or 14 days of one-legged knee immobilization using a full leg cast. After just 5 days, quadriceps cross-sectional area had already declined 3.5 ± 0.5% (P<0.0001), leg lean mass showed a 1.4 ± 0.7% decline trending toward but not reaching significance (P=0.07), and knee-extensor strength had dropped 9.0 ± 2.3% (P<0.0001). By 14 days, the same measures had roughly doubled: cross-sectional area down 8.4 ± 2.8% (P<0.001), lean mass down 3.1 ± 0.7% (P<0.01), strength down 22.9 ± 2.6% (P<0.001). Muscle myostatin mRNA — a gene limiting muscle growth — had doubled by 5 days and stayed elevated at 14 in both groups; breakdown-pathway markers (MAFBx and MuRF1 mRNA) also rose early. The authors concluded "even short periods of muscle disuse can cause substantial loss of skeletal muscle mass and strength."
The rate isn't fixed — studies disagree on the exact numbers
Not every trial found the same magnitude of loss over a similar timeframe — itself an important finding. A 10-day cast-immobilization trial in 8 young women found a quadriceps cross-sectional area decline of 11.8% and a leg-extension one-rep-max strength decline of 41.6% (both P<0.01) — considerably steeper than the 14-day losses above. That same trial also measured sarcoplasmic reticulum calcium uptake rate, a specific contraction mechanism, which declined 13.2% by day 3 (P=0.05) and 19.8% by day 10 (P<0.01). The gap between 22.9% strength loss at 14 days in one study and 41.6% at 10 days in another likely reflects real differences in sample (all-female vs. mixed/male), size (8 vs. 24), and strength test used, rather than one fixed "rate" of human disuse atrophy. A separate trial in 30 people undergoing 14 days of immobilization found starting muscle size did not predict the amount lost overall — though in the 9 women specifically, starting leg fat-free mass and quadriceps size did correlate with subsequent atrophy (r=0.54-0.68, P<0.05), a possible sex difference the authors flagged as needing confirmation.
What's driving the loss, mechanistically, is less dramatic than expected
Rodent studies have suggested disuse atrophy is driven substantially by a surge in protein breakdown linked to oxidative stress. A human trial tracking 21 young adults through 14 days of one-legged immobilization tested this directly, measuring ubiquitin-protein conjugates, caspase 3/7 activity, an actin breakdown fragment, and two oxidative-stress markers from biopsies at baseline, day 2, and day 14 — while confirming the expected 5.7 ± 1.1% decline in quadriceps cross-sectional area (P<0.0001). Ubiquitin-protein conjugates were modestly elevated at day 2 (+12%, P<0.05) but back to baseline by day 14; none of the other markers changed significantly at any point. The authors concluded that, unlike in some rodent models, sustained elevations in these breakdown and oxidative pathways did not appear to drive straightforward human disuse atrophy over two weeks.
Countermeasures help, but even sophisticated ones fall short at longer durations
A trial testing whether minimal resistance exercise could offset 14 days of leg immobilization had 17 people wear a non-weight-bearing knee brace, with about half performing low-volume resistance exercise (roughly 140 total contractions across two weeks, every other day). The non-exercising control group showed significant declines in muscle fiber size, thigh cross-sectional area, and knee-extensor and plantarflexor strength (P<0.01 to P<0.05); the exercising group did not, though calf size still declined significantly in both (more so in control). At longer durations, protection gets harder. A 21-day bed-rest crossover trial in 9 healthy young men found resistive vibration exercise partially preserved insulin sensitivity and muscle mitochondrial respiration versus a no-exercise control, but both groups still lost body mass (-3.2 ± 0.5 kg vs. -2.8 ± 0.4 kg) and fat-free mass (-2.9 ± 0.5 kg vs. -2.7 ± 0.5 kg, both P<0.05 vs. baseline). At 60 days — among the longest controlled durations studied — a trial testing cycling with and without artificial gravity found neuromuscular function, measured by maximal voluntary contraction and jump performance, "deteriorated similarly across groups" regardless of countermeasure, even though the artificial-gravity group better preserved fat-free mass and resting metabolic rate (+133 kcal/day vs. control, P=0.017) and alone showed increased cycling power. The authors' summary: exercise plus artificial gravity "preserves resting metabolism but does not prevent neuromuscular decline."
What we don't know yet
Why the exact rate of loss varies so much between studies. A 10-day, all-female trial found a much steeper strength decline than a 14-day, largely male trial using a similar design — sex, sample size, and testing method are plausible explanations, but none was tested head-to-head here.
How long recovery takes once normal activity resumes. None of the trials retrieved here followed participants after the disuse period ended to measure how quickly strength and size returned to baseline.
What fully protects neuromuscular function over longer durations. Even the most elaborate countermeasure here — cycling plus artificial gravity over 60 days — preserved metabolic and tissue measures without preventing the decline in contractile function.
Whether the same rates apply outside young, healthy volunteers. Nearly all trials retrieved here enrolled healthy young adults; how these atrophy rates apply to older adults or people recovering from illness or surgery was not directly tested here.
What role oxidative stress and protein breakdown pathways play beyond the two-week mark. The one trial that measured these markers directly found no sustained elevation through 14 days, but whether that pattern holds at 21, 60, or more days of disuse was not tested by the same methodology in this search.
Sources
- Wall BT, Dirks ML, Snijders T, Senden JMG, Dolmans J, van Loon LJC. Substantial skeletal muscle loss occurs during only 5 days of disuse. Acta Physiologica, 2013;210(3):600-611. DOI
- Thom JM, Thompson MW, Ruell PA, Bryant GJ, Fonda JS, Harmer AR, Janse de Jonge XA, Hunter SK. Effect of 10-day cast immobilization on sarcoplasmic reticulum calcium regulation in humans. Acta Physiologica Scandinavica, 2001;172(2):141-147. DOI
- Glover EI, Yasuda N, Tarnopolsky MA, Abadi A, Phillips SM. Little change in markers of protein breakdown and oxidative stress in humans in immobilization-induced skeletal muscle atrophy. Applied Physiology, Nutrition, and Metabolism, 2010;35(2):125-133. DOI
- Oates BR, Glover EI, West DW, Fry JL, Tarnopolsky MA, Phillips SM. Low-volume resistance exercise attenuates the decline in strength and muscle mass associated with immobilization. Muscle & Nerve, 2010;42(4):539-546. DOI
- Kenny HC, Rudwill F, Breen L, Salanova M, Blottner D, Heise T, Heer M, Blanc S, O'Gorman DJ. Bed rest and resistive vibration exercise unveil novel links between skeletal muscle mitochondrial function and insulin resistance. Diabetologia, 2017;60(8):1491-1501. DOI
- Coffey VG, McGlory C, Phillips SM, Doering TM. Does initial skeletal muscle size or sex affect the magnitude of muscle loss in response to 14 days immobilization? Applied Physiology, Nutrition, and Metabolism, 2023;48(5):411-416. DOI
- Martin-Rodriguez S, Mandić M, Laurens C, Bareille MP, Billette de Villemeur R, Fernandez-Gonzalo R, Simon C. Artificial gravity during prolonged bed rest preserves resting metabolic rate but not muscle function: Evidence from the BRACE study. The Journal of Physiology, 2026;604(12):4771-4794. DOI
Article records maintained via PubMed. Peptide Proof reports what studies found. It does not provide medical advice, dosing guidance, or treatment recommendations.
Topic: Recovery & Tissue Research
Sources
- Substantial skeletal muscle loss occurs during only 5 days of disuse
- Acta Physiologica, 2013 · n=24 · DOI
- Effect of 10-day cast immobilization on sarcoplasmic reticulum calcium regulation in humans
- Acta Physiologica Scandinavica, 2001 · n=8 · DOI
- Little change in markers of protein breakdown and oxidative stress in humans in immobilization-induced skeletal muscle atrophy
- Applied Physiology, Nutrition, and Metabolism, 2010 · n=21 · DOI
- Low-volume resistance exercise attenuates the decline in strength and muscle mass associated with immobilization
- Muscle & Nerve, 2010 · n=17 · DOI
- Bed rest and resistive vibration exercise unveil novel links between skeletal muscle mitochondrial function and insulin resistance
- Diabetologia, 2017 · n=9 · DOI
- Does initial skeletal muscle size or sex affect the magnitude of muscle loss in response to 14 days immobilization?
- Applied Physiology, Nutrition, and Metabolism, 2023 · n=30 · DOI
- Artificial gravity during prolonged bed rest preserves resting metabolic rate but not muscle function: Evidence from the BRACE study
- The Journal of Physiology, 2026 · n=24 · DOI
Get the evidence, not the hype.
New research briefs, plainly written and fully sourced. No dosing advice, ever.